FORGOT YOUR DETAILS?

The Annual Bay Area Symposium on Viruses was held on Friday, May 29th in the Chan Shun Auditorium on UC Berkeley’s main campus. This was the 5th year of the symposium, which brought together approximately 300 members of the Bay Area virology community for a series of scientific talks by faculty, industry representatives, post-docs, and

On Friday January 9, UC Berkeley’s Wheeler Center for Emerging and Neglected Infectious Diseases (CEND) held its 7th Annual Symposium at the Li Ka Shing Center on Berkeley’s main campus. Running under the theme of “Vaccines and Therapeutics for Emerging and Neglected Infectious Disease: From Science to Solutions,” the event was attended by approximately 300

The Alber Family and Berkeley faculty together have set a goal of raising $50,000 to name an ongoing lecture series in honor of  Tom Alber, founding faculty director of CEND. We hope that you will join us in celebrating his legacy and that you will consider making a gift to help establish a lecture series

Searle Scholars Program 2014  Press Release: Fifteen Searle Scholars Named for 2014 April 4, 2014: Chicago, Illinois – Fifteen researchers in the chemical and biological sciences have been named as the 2014 Searle Scholars. Each will be awarded $300,000 to support his or her work during the next three years. Since the program’s inception in

On January 9, 2014,  the PoCDx IdeaLab, Tekla Labs, and the Henry Wheeler Center for Emerging & Neglected Diseases (CEND) hosted a workshop on the design, development, and implementation of global health technologies. The event attracted over 100 attendees from academia, industry, and the non-profit sector. Videos from the keynote speakers and panel discussion are available

On January 11 and 12th, 2014, the Henry Wheeler Center for Emerging and Neglected Diseases (CEND), Tekla Labs, and the Invention Lab @ CITRIS hosted a unique hack-a-thon on the UC Berkeley campus, “Diagnostics by Design: a hack day for global health.” The Diagnostics by Design hackathon was designed as a cross-communities effort to bridge

Dr. Madhukar Pai, MD, PhD, of McGill University has compiled a list of resources for diagnostics developers working in the tuberculosis field: UNITAID TB Dx technology and market landscape. 2013 semi-annual update. http://www.unitaid.org/images/marketdynamics/publications/UNITAID-TB_Dx_Landscape-Update_Dec%202013.pdf Robust, reliable and resilient: designing molecular tuberculosis tests for microscopy centers in developing countries. http://www.expert-reviews.com/doi/full/10.1586/14737159.2013.850034 Are peripheral microscopy centres ready for next generation molecular tuberculosis

Twelve years after a breakthrough at UC Berkeley, a discovery from the laboratory of Dr. Jay Keasling will finally be reaching those in need. On April 11, 2013, Sanofi launched production of semi-synthetic artemisinin, a key ingredient in the current gold standard for malaria treatment. Read the full story at the UC Berkeley News Center.

The UC Berkeley Minority Health/Global Health (MH/GH) Training Program aims to provide international research experience and training in the health sciences and public health for undergraduate and graduate students committed to reducing U.S. and international health disparities. The program is largely built on the philosophy that providing underrepresented students with the opportunity to bring knowledge

TOP UA-36873340-1